Alchemy Labs Inc. (TSXV:ALCH)
Canada · Delayed Price · Currency is CAD 1.000
0.00 (0.00%)
Jul 9, 2026, 9:32 AM EST
Alchemy Labs Statistics
Total Valuation
| Market Cap | n/a |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | 18.72% |
| Owned by Institutions (%) | 0.80% |
| Float | 43.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.31
| Current Ratio | 0.31 |
| Quick Ratio | 0.22 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.92 |
| Interest Coverage | -2.73 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 112.44% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2,721 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Alchemy Labs had revenue of CAD 1.41 million and -6.71 million in losses. Loss per share was -0.24.
| Revenue | 1.41M |
| Gross Profit | -32,429 |
| Operating Income | -4.36M |
| Pretax Income | -6.71M |
| Net Income | -6.71M |
| EBITDA | -4.32M |
| EBIT | -4.36M |
| Loss Per Share | -0.24 |
Balance Sheet
The company has 1.91 million in cash and 8.43 million in debt, with a net cash position of -6.52 million.
| Cash & Cash Equivalents | 1.91M |
| Total Debt | 8.43M |
| Net Cash | -6.52M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -5.63M |
| Book Value Per Share | -0.20 |
| Working Capital | -7.62M |
Cash Flow
In the last 12 months, operating cash flow was -3.89 million and capital expenditures -496,897, giving a free cash flow of -4.39 million.
| Operating Cash Flow | -3.89M |
| Capital Expenditures | -496,897 |
| Depreciation & Amortization | 27,092 |
| Net Borrowing | 8.05M |
| Free Cash Flow | -4.39M |
| FCF Per Share | n/a |
Margins
| Gross Margin | -2.30% |
| Operating Margin | -309.27% |
| Pretax Margin | -475.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Alchemy Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Alchemy Labs has an Altman Z-Score of -6.76 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.76 |
| Piotroski F-Score | 1 |